IVF is a common genetic and ethical topic. Through IVF individuals can produce offspring successfully when natural procreation is not viable. However, in vitro can become genetically specific and allow for the selection of particular genes or expressible traits to be dominantly present in the formed embryo. Ethical dilemmas arise when determining health care coverage and the deviation from natural selection and gene variations. In regards to multiple births different ethical concerns arise from the use of in vitro fertilization. Overall, multiple pregnancies can cause potential harm to the mother and children due to potential complications. Such complications can include uterine bleeding and children not receiving equal nutrients. IVF has also revealed some pre term deliveries and lower birth weights in babies. While some view medically assisted procreation as a saving grace to have children, others consider these procedure to be unnatural and costly to the community. Multifetal pregnancy reduction
Multifetal pregnancy reduction is the reduction of one or more embryos from the bearing woman. Selective reduction usually occurs for pregnancies assisted by assisted reproductive technology (ART). The first multifetal pregnancy reductions to occur in a clinical setting took place in the 1980s. The procedure aims to reduce pregnancies down to approximately one to two fetuses. The overarching purpose of the procedure is not primarily to simply terminate life, but to increase the survival and success of the mother and babies. However, multifetal pregnancy reduction raises some ethical questions. The main argument is similar to abortion ethics (Abortion debate) in reduction of fetus versus fetus life.
Granular corneal dystrophy  is a slowly progressive corneal dystrophy that most often begins in early childhood. Granular corneal dystrophy has two types:

Granular corneal dystrophy type I, also corneal dystrophy Groenouw type I, is a rare form of human corneal dystrophy. It was first described by German ophthalmologist Arthur Groenouw in 1890. Granular corneal dystrophy type II, also called Avellino corneal dystrophy or combined granular-lattice corneal dystrophy is also a rare form of corneal dystrophy. The disorder was first described by Folberg et al. in 1988. The name Avellino corneal dystrophy comes from the first four patients in the original study each tracing their family origin to the Italian province of Avellino. Presentation
Granular corneal dystrophy is diagnosed during an eye examination by an ophthalmologist or optometrist. The lesions consist of central, fine, whitish granular lesions in the cornea. Visual acuity is slightly reduced. Genetics
Granular corneal dystrophy is caused by a mutation in the TGFBI gene, located on chromosome 5q31. The disorder is inherited in an autosomal dominant manner. This indicates that the defective gene responsible for the disorder is located on an autosome (chromosome 5 is an autosome), and only one copy of the gene is sufficient to cause the disorder, when inherited from a parent who has the disorder. The gene TGFBI encodes the protein keratoepithelin. Diagnosis
Treatment
Corneal transplant is not needed except in very severe and late cases. Light sensitivity may be overcome by wearing tinted glasses. See also
Corneal dystrophy


== References ==